Cambridge, Mass. — October 16, 2025 — Leads & Copy — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO) will host a conference call and live webcast on Thursday, October 30, 2025, at 8:00 a.m. ET to report its third quarter 2025 financial results and business highlights.
The live webcast will be accessible on the Investors section of the company’s website (www.agios.com) under the “Events & Presentations” tab. A replay of the webcast will be available on the company’s website approximately two hours after the event.
At Agios, their vision is to redefine the future of rare disease treatment. Fueled by connections, they build trusted partnerships with communities – collaborating to develop and deliver innovative medicines that have the potential to transform lives. With a foundation in hematology, they combine biological expertise with real-world insights to advance a growing pipeline of rare disease medicines that reflect the priorities of the people they serve. Agios is a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts.
Contact:
Investor Contact: Morgan Sanford, Vice President, Investor Relations, Agios Pharmaceuticals, morgan.sanford@agios.com
Media Contact: Eamonn Nolan, Senior Director, Corporate Communications, Agios Pharmaceuticals, eamonn.nolan@agios.com
Source: Agios Pharmaceuticals, Inc.
